Gwenn Hansen

Chief Scientific Officer

Chief Scientific Officer at Nurix Therapeutics, Inc., filing insider transactions between 2026-07-30 and 2026-09-01.

Total Purchases

—

0 transactions

Total Sales

$336K

5 transactions

Companies Traded

5 total filings

Active Since

2026-07-30

Last: 2026-09-01

Companies

Nurix Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-09-01	NRIX	Sale	1,452	$25.47	$37K	117.2K	SEC ↗
2026-08-05	NRIX	Sale	4,356	$25.00	$109K	117.2K	SEC ↗
2026-08-04	NRIX	Sale	1,500	$23.87	$36K	119.8K